D Billot-Klein

1.1k total citations
18 papers, 866 citations indexed

About

D Billot-Klein is a scholar working on Infectious Diseases, Molecular Biology and Molecular Medicine. According to data from OpenAlex, D Billot-Klein has authored 18 papers receiving a total of 866 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 8 papers in Molecular Biology and 7 papers in Molecular Medicine. Recurrent topics in D Billot-Klein's work include Antimicrobial Resistance in Staphylococcus (11 papers), Antibiotic Resistance in Bacteria (7 papers) and Bacterial Genetics and Biotechnology (5 papers). D Billot-Klein is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (11 papers), Antibiotic Resistance in Bacteria (7 papers) and Bacterial Genetics and Biotechnology (5 papers). D Billot-Klein collaborates with scholars based in France and Morocco. D Billot-Klein's co-authors include Ludwig Gutmann, Jean van Heijenoort, E. Collatz, Guy Tran Van Nhieu, R. Williamson, Sophie Sablé, Éric Guittet, F. W. Goldstein, Laurie Gutmann and J. F. Acar and has published in prestigious journals such as Clinical Infectious Diseases, Biochemical Journal and Journal of Bacteriology.

In The Last Decade

D Billot-Klein

18 papers receiving 823 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D Billot-Klein France 16 414 335 326 168 165 18 866
Monique Malléa France 16 791 1.9× 170 0.5× 391 1.2× 131 0.8× 266 1.6× 23 1.2k
D. H. Bouanchaud France 19 362 0.9× 522 1.6× 595 1.8× 156 0.9× 307 1.9× 31 1.4k
M Scavizzi France 13 264 0.6× 141 0.4× 238 0.7× 132 0.8× 255 1.5× 25 728
Debra M. Mills United States 12 556 1.3× 255 0.8× 251 0.8× 283 1.7× 151 0.9× 14 1.2k
C.-J. Soussy France 15 272 0.7× 223 0.7× 146 0.4× 127 0.8× 58 0.4× 29 664
K. Coleman United States 8 305 0.7× 187 0.6× 414 1.3× 43 0.3× 138 0.8× 8 839
H. M. Van Den Elzen Canada 10 499 1.2× 137 0.4× 356 1.1× 79 0.5× 183 1.1× 10 832
Barry Barton United Kingdom 11 460 1.1× 125 0.4× 534 1.6× 124 0.7× 99 0.6× 12 1.0k
Margareta Tuckman United States 19 424 1.0× 275 0.8× 355 1.1× 41 0.2× 153 0.9× 24 1.0k
B Oliva Italy 17 203 0.5× 207 0.6× 379 1.2× 182 1.1× 113 0.7× 33 900

Countries citing papers authored by D Billot-Klein

Since Specialization
Citations

This map shows the geographic impact of D Billot-Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Billot-Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Billot-Klein more than expected).

Fields of papers citing papers by D Billot-Klein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Billot-Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Billot-Klein. The network helps show where D Billot-Klein may publish in the future.

Co-authorship network of co-authors of D Billot-Klein

This figure shows the co-authorship network connecting the top 25 collaborators of D Billot-Klein. A scholar is included among the top collaborators of D Billot-Klein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Billot-Klein. D Billot-Klein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Mainardi, Jean‐Luc, et al.. (1998). Resistance to cefotaxime and peptidoglycan composition in Enterococcus faecalis are influenced by exogenous sodium chloride. Microbiology. 144(10). 2679–2685. 11 indexed citations
2.
3.
Billot-Klein, D, Raymond Legrand, Bernard Schoot, Jean van Heijenoort, & Ludwig Gutmann. (1997). Peptidoglycan structure of Lactobacillus casei, a species highly resistant to glycopeptide antibiotics. Journal of Bacteriology. 179(19). 6208–6212. 37 indexed citations
4.
Gutmann, Ludwig, et al.. (1996). Penicillin tolerance and modification of lipoteichoic acid associated with expression of vancomycin resistance in VanB-type Enterococcus faecium D366. Antimicrobial Agents and Chemotherapy. 40(1). 257–259. 15 indexed citations
5.
Billot-Klein, D, et al.. (1996). Peptidoglycan structure of Enterococcus faecium expressing vancomycin resistance of the VanB type. Biochemical Journal. 313(3). 711–715. 29 indexed citations
6.
Billot-Klein, D, et al.. (1996). Peptidoglycan synthesis and structure in Staphylococcus haemolyticus expressing increasing levels of resistance to glycopeptide antibiotics. Journal of Bacteriology. 178(15). 4696–4703. 54 indexed citations
7.
Rosato, Adriana E., Juliette Pierre, D Billot-Klein, Annie Buu-Hoï, & Ludwig Gutmann. (1995). Inducible and constitutive expression of resistance to glycopeptides and vancomycin dependence in glycopeptide-resistant Enterococcus avium. Antimicrobial Agents and Chemotherapy. 39(4). 830–833. 36 indexed citations
8.
9.
Gutmann, Ludwig, et al.. (1994). Synergy and resistance to synergy between beta-lactam antibiotics and glycopeptides against glycopeptide-resistant strains of Enterococcus faecium. Antimicrobial Agents and Chemotherapy. 38(4). 824–829. 29 indexed citations
10.
Al-Obeid, S., D Billot-Klein, Jean van Heijenoort, E. Collatz, & Ludwig Gutmann. (1992). Replacement of the essential penicillin-binding protein 5 by high-molecular mass PBPs may explain vancomycin-β-lactam synergy in low-level vancomycin-resistant Enterococcus faecium D366. FEMS Microbiology Letters. 91(1). 79–84. 2 indexed citations
11.
Gutmann, Ludwig, D Billot-Klein, S. Al-Obeid, et al.. (1992). Inducible carboxypeptidase activity in vancomycin-resistant enterococci. Antimicrobial Agents and Chemotherapy. 36(1). 77–80. 62 indexed citations
12.
Billot-Klein, D, Ludwig Gutmann, E. Collatz, & Jean van Heijenoort. (1992). Analysis of peptidoglycan precursors in vancomycin-resistant enterococci. Antimicrobial Agents and Chemotherapy. 36(7). 1487–1490. 35 indexed citations
13.
Billot-Klein, D, Laurie Gutmann, & E. Collatz. (1990). Nucleotide sequence of the SHV-5 beta-lactamase gene of a Klebsiella pneumoniae plasmid. Antimicrobial Agents and Chemotherapy. 34(12). 2439–2441. 55 indexed citations
14.
Collatz, E., Guy Tran Van Nhieu, D Billot-Klein, R. Williamson, & Laurie Gutmann. (1989). Substitution of serine for arginine in position 162 of TEM-type β-lactamases extends the substrate profile of mutant enzymes, TEM-7 and TEM-101, to ceftazidime and aztreonam. Gene. 78(2). 349–354. 45 indexed citations
15.
Gutmann, Ludwig, Marie-Dominique Kitzis, D Billot-Klein, et al.. (1988). Plasmid-Mediated  -Lactamase (TEM-7) Involved in Resistance to Ceftazidime and Aztreonam. Clinical Infectious Diseases. 10(4). 860–866. 94 indexed citations
16.
Gutmann, Ludwig, D Billot-Klein, R. Williamson, et al.. (1988). Mutation of Salmonella paratyphi A conferring cross-resistance to several groups of antibiotics by decreased permeability and loss of invasiveness. Antimicrobial Agents and Chemotherapy. 32(2). 195–201. 40 indexed citations
17.
Kitzis, M, D Billot-Klein, F. W. Goldstein, et al.. (1988). Dissemination of the novel plasmid-mediated beta-lactamase CTX-1, which confers resistance to broad-spectrum cephalosporins, and its inhibition by beta-lactamase inhibitors. Antimicrobial Agents and Chemotherapy. 32(1). 9–14. 97 indexed citations
18.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Monique Malléa Breakdown of academic impact, for papers by D. H. Bouanchaud Breakdown of academic impact, for papers by M Scavizzi Breakdown of academic impact, for papers by Debra M. Mills Breakdown of academic impact, for papers by C.-J. Soussy Breakdown of academic impact, for papers by K. Coleman Breakdown of academic impact, for papers by H. M. Van Den Elzen Breakdown of academic impact, for papers by Barry Barton Breakdown of academic impact, for papers by Margareta Tuckman Breakdown of academic impact, for papers by B Oliva
Rankless by CCL
2026